Maestro Clinical is a Global Research Organization that provides comprehensive operational support and clinical trial management to the China Clinical Trials Consortium, a first of its kind, coordinated network of clinical research excellence in China.

Maestro and the CCTC represent a collaboration between Chinese and Western clinical leaders working together with seasoned drug development professionals and are dedicated to realization of the enormous potential for fully ICH-GCP compliant innovative clinical development in China.

With an initial focus on Oncology, Maestro provides a critical link in enabling realization of the tremendous opportunity to accelerate the global development of novel cancer treatments.